Asia-Pacific Immunodiagnostics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product [Enzyme-Linked Immunosorbent Assays (ELISA), Chemiluminescence Immunoassays (CLIA), Radioimmunoassays (RIA), and Others], Clinical Indication (Infectious Diseases, Hepatitis+HIV, Endocrinology, Gastrointestinal, Metabolics, and Others), and End User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others)   

Code: BMIRE00027857 | Pages: 220 | Industry: Biotechnology | Date: Jan 2023 | Type: Regional

The Asia-Pacific immunodiagnostics market is expected to grow from US$ 2,231.31 million in 2022 to US$ 3,587.50 million by 2028; it is estimated to grow at a CAGR of 8.2% from 2022 to 2028.  

 

Increasing Prevalence of Infectious Diseases Supports Asia-Pacific Immunodiagnostics Market Growth

 

The diagnosis and management of several ever-growing infectious diseases caused by infectious agents such as viruses, fungi, bacteria, parasites, or their toxic products are increasing the number of prescriptions for immunodiagnostic tests—complement fixation, precipitation tests, agglutination tests, line blot assays, western blot assays, enzyme immunoassays (EIA), and immunofluorescence tests. For instance, according to the World Health Organization (WHO), approximately 58 million people worldwide suffer from chronic hepatitis C infection, with 1.5 million new conditions occurring every year. Approximately 3.2 million adolescents and children suffer from this infection. Diagnostics play a vital role in determining the direction of any medical treatment. Immunodiagnostics help diagnose diseases that severely impact the immune system. All these factors indicate that the rising prevalence of infectious diseases leads to the surging demand for immunodiagnostic products, which is supporting the Asia-Pacific immunodiagnostics market

 

Asia-Pacific Immunodiagnostics Market Overview

 

Asia Pacific (Asia-Pacific) is the fastest-growing market for immunodiagnostics. The Asia-Pacific immunodiagnostic market is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia-Pacific. The increasing prevalence of chronic illness in Asia-Pacific is boosting the demand for diagnostic tests that provide essential details of medical care with detection, diagnostics, and therapy related to the disease. During 2010–2020, Asia-Pacific witnessed a 39% increase in the number of immunology trials, a significant rise as compared to other regions. In 2020, the maximum number of immunology trials occurred in China, followed by Japan and India. According to Statista, a large chunk of the Chinese population was suffering from chronic diseases in 2020, while in 2019, chronic conditions caused 88.5% of mortalities in the country. The country’s geriatric population and the prevalence of chronic illnesses are increasing. Approximately 80% of deaths among the people aged 60 years in the country are caused due to chronic NCDs, of which the most severe are ischemic heart disease, stroke, chronic obstructive pulmonary disease (COPD), and type II diabetes. The incidence of chronic diseases such as cancer, diabetes, cardiovascular diseases (CVDs), and tuberculosis is increasing in the country due to rapid urbanization, which is expected to surge the demand for immunodiagnostic tests.

 

Asia-Pacific Immunodiagnostic Market Revenue and Forecast to 2028 (US$ Million) 

 

APAC Immunodiagnostic Market Revenue and Forecast to 2028 (US$ Million) 

Get more information on this report :

                  

 

Asia-Pacific Immunodiagnostic Market Segmentation

 

The Asia-Pacific immunodiagnostic market is segmented into product, clinical indication, end user, and country.  

 

Based on product, the Asia-Pacific immunodiagnostic market is segmented into enzyme-linked immunosorbent assays (ELISA), chemiluminescence immunoassays (CLIA), radioimmunoassay (RIA), and others. The enzyme-linked immunosorbent assays (ELISA) segment registered the largest market share in 2022.

 

Based on clinical indication, the Asia-Pacific immunodiagnostic market is segmented into infectious diseases, hepatitis+HIV, endocrinology, gastrointestinal, metabolics, and others. The infectious diseases segment registered the largest market share in 2022.

 

Based on end user, the Asia-Pacific immunodiagnostic market is segmented into hospitals, clinics, diagnostics laboratories, academic and research institutes, and others. The hospital segment registered the largest market share in 2022.

 

Based on country, the Asia-Pacific immunodiagnostic market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia-Pacific. China dominated the market in 2022.

 

Abbott Laboratories; bioMerieux SA; Danaher Corp; DiaSorin S.p.A.; F. Hoffmann-La Roche Ltd; PerkinElmer Inc.; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Siemens Healthineers AG; Svar Life Science AB; and Thermo Fisher Scientific Inc are the leading companies operating in the Asia-Pacific immunodiagnostic market.

1.           Introduction

1.1         Study Scope

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia-Pacific Immunodiagnostics Market – By Product

1.3.2        Asia-Pacific Immunodiagnostics Market – By Clinical Indication

1.3.3        Asia-Pacific Immunodiagnostics Market – By End User

1.3.4        Asia-Pacific Immunodiagnostics Market– By Country

2.           Asia-Pacific Immunodiagnostics Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Asia-Pacific Immunodiagnostics Market– Market Landscape

4.1         Overview

4.2         Asia-Pacific PEST Analysis

4.3         Experts Opinion

5.           Asia-Pacific Immunodiagnostics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Infectious Diseases

5.1.2        Increasing Use of Point-of-Care Immunodiagnostics

5.2         Market Restraints

5.2.1        Inadequate Reimbursement Scenario

5.3         Market Opportunities

5.3.1        Rising Focus on R&D Investment and Expansion by Key Players

5.4         Future Trends

5.4.1        Technological Advancements in Immunodiagnostics

5.5         Impact Analysis

6.           Immunodiagnostics Market– Asia-Pacific Analysis

6.1         Asia-Pacific Immunodiagnostics Market Revenue Forecast and Analysis

7.           Asia-Pacific Immunodiagnostics Market Analysis – by Product

7.1         Overview

7.2         Asia-Pacific Immunodiagnostics Market, By Product, 2021 & 2028 (%)

7.3         Enzyme-linked immunosorbent assays (ELISA)

7.3.1        Overview

7.3.2        Enzyme-linked immunosorbent assays (ELISA): Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4         Chemiluminescence immunoassays (CLIA)

7.4.1        Overview

7.4.2        Chemiluminescence immunoassays (CLIA): Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4.3        Vitamin D Assay

7.4.3.1          Overview

7.4.3.2          Vitamin D Assay: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4.4        HIV Detection

7.4.4.1          Overview

7.4.4.2          HIV Detection: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4.5        HIV Ag/Ab Combo assay

7.4.5.1          Overview

7.4.5.2          HIV Ag/Ab Combo assay: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4.6        Other Tests

7.4.6.1          Overview

7.4.6.2          Other Tests: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.5         Radioimmunoassays (RIA)

7.5.1        Overview

7.5.2        Radioimmunoassays (RIA): Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.6         Others

7.6.1        Overview

7.6.2        Others: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

8.           Asia-Pacific Immunodiagnostics Market Analysis – Clinical Indication

8.1         Overview

8.2         Asia-Pacific Immunodiagnostics Market Share by Clinical Indication - 2021 & 2028 (%)

8.3         Infectious Diseases:

8.3.1        Overview

8.3.2        Infectious Diseases: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.3        COVID-19

8.3.3.1          Overview

8.3.3.2          COVID-19: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.4        Tuberculosis

8.3.4.1          Overview

8.3.4.2          Tuberculosis: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.5        Lyme

8.3.5.1          Overview

8.3.5.2          Lyme: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.6        Infection Management

8.3.6.1          Overview

8.3.6.2          Infection Management: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.7        Zika

8.3.7.1          Overview

8.3.7.2          Zika: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.8        Treponema

8.3.8.1          Overview

8.3.8.2          Treponema: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.9        TORCH

8.3.9.1          Overview

8.3.9.2          TORCH: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.10     Measles and Mumps

8.3.10.1       Overview

8.3.10.2       Measles and Mumps: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.11     VZV

8.3.11.1       Overview

8.3.11.2       VZV: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.12     EBV

8.3.12.1       Overview

8.3.12.2       EBV: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4         Hepatitis+HIV:

8.4.1        Overview

8.4.2        Hepatitis+HIV: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.5         Gastrointestinal

8.5.1        Overview

8.5.2        Gastrointestinal: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.6         Metabolics

8.6.1        Overview

8.6.2        Metabolics: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7         Endocrinology

8.7.1        Overview

8.7.2        Endocrinology: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7.3        Hypertension

8.7.3.1          Overview

8.7.3.2          Hypertension: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7.4        Growth

8.7.4.1          Overview

8.7.4.2          Growth: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7.5        Diabetes

8.7.5.1          Overview

8.7.5.2          Diabetes: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7.6        Thyroid

8.7.6.1          Overview

8.7.6.2          Thyroid: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7.7        Reproductive Endocrinology

8.7.7.1          Overview

8.7.7.2          Reproductive endocrinology: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.8         Others

8.8.1        Overview

8.8.2        Others: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.           Asia-Pacific Immunodiagnostics Market Analysis – End User

9.1         Overview

9.2         Asia-Pacific Immunodiagnostics Market Share by End User - 2021 & 2028 (%)

9.3         Hospitals

9.3.1        Overview

9.3.2        Hospitals: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.4         Clinics

9.4.1        Overview

9.4.2        Clinics: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.5         Diagnostic Laboratories

9.5.1        Overview

9.5.2        Diagnostic Laboratories: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.6         Academic and Research Institutes

9.6.1        Overview

9.6.2        Academic and Research Institutes: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.7         Others

9.7.1        Overview

9.7.2        Others: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.        Asia-Pacific Immunodiagnostics Market Revenue and Forecast to 2028– by Country

10.1      Overview

10.1.1     Asia Pacific: Immunodiagnostics Market, by Country, 2021 & 2028 (%)

10.1.1.1       China: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.1       China: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.2       China Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.2.1    China Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)

10.1.1.1.3       China Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.3.1    China Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.3.2    China Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.4       China: Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.2       Japan: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.1       Japan: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.2       Japan Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.2.1    Japan Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.3       Japan Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.3.1    Japan Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.3.2    Japan Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.4       Japan Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.3       India: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.1       India: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.2       India Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.2.1    India Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.3       India Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.3.1    India Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.3.2    India Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.4       India Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.4       Australia: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.1       Australia: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.2       Australia Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.2.1    Australia Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.3       Australia Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.3.1    Australia Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.3.2    Australia Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.4       Australia Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.5       South Korea: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.1       South Korea: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.2       South Korea Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.2.1    South Korea Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.3       South Korea Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.3.1    South Korea Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.3.2    South Korea Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.4       South Korea Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.6       Rest of Asia Pacific: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.1       Rest of Asia Pacific: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.2       Rest of Asia Pacific Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.2.1    Rest of Asia Pacific Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.3       Rest of Asia Pacific Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.3.1    Rest of Asia Pacific Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.3.2    Rest of Asia Pacific Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.4       Rest of Asia Pacific Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.        Asia-Pacific Immunodiagnostics Market –Industry Landscape

11.1      Overview

11.2      Inorganic Growth Strategies

11.2.1     Overview

11.3      Organic Growth Strategies

11.3.1     Overview

12.        Company Profiles

12.1      Abbott Laboratories

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      F. Hoffmann-La Roche Ltd

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      DiaSorin S.p.A.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Danaher Corp

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Thermo Fisher Scientific Inc

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      PerkinElmer Inc.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      bioMerieux SA

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Svar Life Science AB

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   Siemens Healthineers AG

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             Asia-Pacific Immunodiagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Table 2.             China Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 3.             China Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)

Table 4.             China Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

Table 5.             China Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 6.             China Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

Table 7.             China Immunodiagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)

Table 8.             Japan Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)

Table 9.             Japan Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)

Table 10.          Japan Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

Table 11.          Japan Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 12.          Japan Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

Table 13.          Japan Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 14.          India Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)

Table 15.          India Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)

Table 16.          India Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

Table 17.          India Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 18.          India Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

Table 19.          India Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 20.          Australia Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)

Table 21.          Australia Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)

Table 22.          Australia Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

Table 23.          Australia Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 24.          Australia Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

Table 25.          Australia Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 26.          South Korea Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)

Table 27.          South Korea Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)

Table 28.          South Korea Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

Table 29.          South Korea Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 30.          South Korea Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

Table 31.          South Korea Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 32.          Rest of Asia Pacific Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)

Table 33.          Rest of Asia Pacific Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028  (USD Million)

Table 34.          Rest of Asia Pacific Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

Table 35.          Rest of Asia Pacific Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 36.          Rest of Asia Pacific Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

Table 37.          Rest of Asia Pacific Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 38.          Recent Inorganic Growth Strategies in the Immunodiagnostics Market

Table 39.          Recent Organic Growth Strategies in the Immunodiagnostics Market

Table 40.          Glossary of Terms, Immunodiagnostics Market

 

 

LIST OF FIGURES

Figure 1.           Asia-Pacific Immunodiagnostics Market Segmentation

Figure 2.           Asia-Pacific Immunodiagnostics Market Segmentation, By Country

Figure 3.           Asia-Pacific Immunodiagnostics Market Overview

Figure 4.           Asia-Pacific Immunodiagnostics Market, by Product

Figure 5.           Asia-Pacific Immunodiagnostics Market, by Country

Figure 6.           Asia-Pacific PEST Analysis

Figure 7.           Asia-Pacific Immunodiagnostics Market: Impact Analysis of Drivers and Restraints

Figure 8.           Asia-Pacific Immunodiagnostics Market– Revenue Forecast and Analysis – 2020 - 2028

Figure 9.           Asia-Pacific Immunodiagnostics Market, by Product, 2021 & 2028 (%)

Figure 10.        Enzyme-linked immunosorbent assays (ELISA): Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 11.        Chemiluminescence immunoassays (CLIA): Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        Vitamin D Assay: Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        HIV Detection: Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        HIV Ag/Ab Combo assay: Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        Other Tests: Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        Radioimmunoassays (RIA): Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        Others: Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        Asia-Pacific Immunodiagnostics Market Share by Clinical Indication - 2021 & 2028 (%)

Figure 19.        Infectious Diseases: Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20.        COVID-19: Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        Tuberculosis: Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        Lyme: Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23.        Infection Management: Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24.        Zika: Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25.        Treponema: Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26.        TORCH: Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27.        Measles and Mumps: Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28.        VZV: Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29.        EBV: Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 30.        Hepatitis+HIV: Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 31.        Gastrointestinal: Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 32.        Metabolics: Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 33.        Endocrinology: Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 34.        Hypertension: Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 35.        Growth: Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 36.        Diabetes: Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 37.        Thyroid: Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 38.        Reproductive endocrinology: Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 39.        Others: Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 40.        Asia-Pacific Immunodiagnostics Market Share by End User - 2021 & 2028 (%)

Figure 41.        Hospitals: Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 42.        Clinics: Asia-Pacific Immunodiagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 43.        Diagnostic Laboratories: Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 44.        Academic and Research Institutes: Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 45.        Others: Asia-Pacific Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 46.        Asia Pacific: Immunodiagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 47.        Asia Pacific: Immunodiagnostics Market, by Country, 2021 & 2028 (%)

Figure 48.        China: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 49.        Japan: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 50.        India: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 51.        Australia: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 52.        South Korea: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 53.        Rest of Asia Pacific: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

  1. Abbott Laboratories
  2. bioMerieux SA
  3. Danaher Corp
  4. DiaSorin S.p.A.
  5. F. Hoffmann-La Roche Ltd
  6. PerkinElmer Inc.
  7. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  8. Siemens Healthineers AG
  9. Svar Life Science AB
  10. Thermo Fisher Scientific Inc
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000